Early signaling via inhibitory and activating NK receptors

Human Immunology

Volumn 61, Issue 1, 2000, Pages 51-64

  Bléry, Mathieu ^a   Olcese, Lucia ^a   Vivier, Eric ^a  

^a INSERM   (France)

Author keywords

ITIM; Kinases, inhibition; NK cells; Phosphatases

Indexed keywords

CELL SURFACE RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL ACTIVATION; CELL FUNCTION; DNA FLANKING REGION; IMMUNOREGULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0242605579     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00157-3     Document Type: Article

References (91)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187.
2. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA-class-I molecules in human natural killer cells. Ann Rev Immunol. 14:1996;619.
3. Lanier L.L., Corliss B., Phillips J.H. Arousal and inhibition of human NK cells. Immunol Rev. 155:1997;145.
4. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense function and regulation by innate cytokines . Ann Rev Immunol. 17:1999;189.
5. Höglund P.J., Sundback J., Olsson-Alheim M.Y., Johansson M., Salcedo M., Öhlen C., Ljunggren H.-G., Sentman C.L., Kärre K. Host MHC class I gene control of NK-cell specificity on the mouse. Immunol Rev. 155:1997;11.
6. Burshtyn D.N., Lam A.S., Weston M., Gupta N., Warmerdam P.A., Long E.O. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors. J Immunol. 162:1999;897.
7. Vély F., Olivero S., Olcese L., Moretta A., Damen J.E., Liu L., Krystal G., Cambier J.L., Daëron M., Vivier E. Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur J Immunol. 27:1997;1994.
8. Burshtyn D.N., Yang W., Yi T., Long E.O. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J Biol Chem. 272:1997;13066.
9. Bruhns P., Marchetti P., Fridman W.H., Vivier E., Daëron M. Differential roles of N- and C-terminal ITIMs during inhibition of cell activation by killer cell inhibitory receptors. J Immunol. 162:1999;3168.
10. Fry A.M., Lanier L.L., Weiss A. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med. 184:1996;295.
11. Olcese L., Lang P., Vély F., Cambiaggi A., Marguet D., Bléry M., Hippen K.L., Biassoni R., Moretta A., Moretta L., Cambier J.L., Vivier E. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol. 156:1996;4531.
12. Burshtyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.P., Long E.O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 4:1996;77.
13. Campbell K.S., Dessing M., Lopez-Botet M., Cella M., Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med. 184:1996;93.
14. Lorenz U., Ravichandran K.S., Burakoff S.J., Neel B.G. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc Natl Acad Sci USA. 93:1996;9624.
15. Pani G., Fisher K.-D., Mlinaric-Rascan I., Siminovitch K.A. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med. 184:1996;839.
16. Valiante N.M., Phillips J.H., Lanier L.L., Parham P. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-γ signalling complex in human NK cells. J Exp Med. 184:1996;2243.
17. Binstadt B.A., Billadeau D.D., Jevremovi-Cacute D., Williams B.L., Fang N., Yi T., Koretzky G.A., Abraham R.T., Leibson P.F. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem. 273:1998;27518.
18. Plas D.R., Johnson R., Pingel J.T., Matthews R.J., Dalton M., Roy G., Chan A.C., Thomas M.L. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science. 272:1996;1173.
19. Dustin L.B., Plas D.R., Wong J., Hu Y.T., Soto C., Chan A.C., Thomas M.L. Expression of dominant-negative Src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. J Immunol. 162:1999;2717.
20. Huyer G., Alexander D.R. Immune signalling SHP-2 docks at multiple ports . Curr Biol. 9:1999;R129.
21. Qu C.K., Yu W.M., Azzarelli B., Feng G.S. Genetic evidence that SHP-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals. Proc Natl Acad Sci USA. 96:1999;8528.
22. Amigorena S., Bonnerot C., Drake J., Choquet D., Hunziker W., Guillet J.-G., Webster P., Sautès C., Mellman I., Fridman W.H. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B-lymphocytes. Science. 256:1992;1808.
23. Muta T., Korosaki T., Misulovin Z., Sanzhez M., Nussenzweig M.C., Ravetch J.V. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signaling. Nature. 368:1994;70.
24. D'Ambrosio D., Hippen K.L., Minskoff S.A., Mellman I., Pani G., Siminovitch K.A., Cambier J.C. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science. 268:1995;293.
25. Daëron M., Latour S., Malbec O., Espinosa E., Pina P., Pasmans S., Fridman W.H. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity. 3:1995;635.
26. Vivier E., Daëron M. Immunoreceptor tyrosine-based inhibition motifs (ITIMs). Immunol Today. 18:1997;286.
27. Daëron M, Vivier E (eds): Immunoreceptor tyrosine-based inhibition motifs. In Current Topics in Microbiology and Immunology (Vol. 244). Berlin: Springer, 1997.
28. Bolland S., Ravetch J.V. Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol. 72:1999;149.
29. Bléry M., Kubagawa H., Chen C.-C., Vély F., Cooper M.D., Vivier E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA. 95:1998;2446.
30. Maeda A., Kurosaki M., Ono M., Takai T., Kurosaki T. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J Exp Med. 187:1998;1355.
31. Uehara T, Bléry M, Chen CC, Vivier E, Cooper MD, Kubagawa H: Cross-linkage of paired immunoglobulin-like receptors with FcεRI on mast cells inhibits IgE-mediated serotonin release (submitted for publication, 1992).
32. Hof P., Pluskey S., Dhe-Paganon S., Eck M.J., Shoelson S.E. Crystal structure of the tyrosine phosphatase SHP-2. Cell. 92:1998;441.
33. Eck M.J., Pluskey S., Trüb T., Harrison S.C., Shoelson S.E. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature. 379:1996;277.
34. Pluskey S., Wandless T.J., Walsh C.T., Shoelson S.E. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem. 270:1995;2897.
35. Pei D., Wang J., Walsh C. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. Proc Natl Acad Sci USA. 93:1996;1141.
36. Vély F., Vivier E. Commentary conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and non-inhibitory/activatory counterparts . J Immunol. 159:1997;2075.
37. Moretta A., Sivori S., Vitale M., Pende D., Morelli L., Augugliaro R., Bottino C., Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 182:1995;875.
38. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., Conte R., Poggi A., Moretta A., Moretta L. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med. 183:1996;645.
39. Biassoni R., Pessino A., Malaspina A., Cantoni C., Bottino C., Sivori S., Moretta L., Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol. 27:1997;3095.
40. Winter C.C., Gumperz J.E., Parham P., Long E.O., Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol. 161:1998;571.
41. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A., Parolini S., Moretta L., Moretta A., Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 198:1999;787.
42. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R., Moretta L., Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 29:1999;1656.
43. Moretta A., Bottino C., Millo R., Biassoni R. HLA-specific and non-HLA-specific human NK receptors. Curr Top Microbiol Immunol. 244:1999;69.
44. Cantoni C., Biassoni R., Pende D., Sivori S., Accame L., Pareti L., Semenzato G., Moretta A., Bottino C. The activating form of CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol. 28:1998;327.
45. Houchins J.P., Lanier L.L., Niemi E.C., Phillips J.H., Ryan J.C. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol. 158:1997;3603.
46. Glienke J., Sobanov Y., Brostjan C., Steffens C., Nguyen C., Lehrach H., Hofer E., Francis F. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics. 48:1998;163.
47. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G., Lazetic S.S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795.
48. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA. 95:1998;5199.
49. Valés-Gomez M., Reyburn H.T., Erskine R.A., Lopez-Botet M., Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:1999;4250.
50. Nakamura M.C., Linnemeyer P.A., Niemi E.C., Mason L.H., Ortaldo J.R., Ryan J.C., Seaman W.E. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med. 189:1999;493.
51. Lanier L.L., Chang C., Philips J.H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol. 153:1994;2117.
52. Ryan J.C., Seaman W.E. Divergent functions of lectin-like receptors on NK cells. Immunol Rev. 155:1997;79.
53. Carlyle J.R., Martin A., Mehra A., Attisano L., Tsui F.W., Zuniga-Pflucker J.C. Mouse NKR-P1B, a novel NK1 1 antigen with inhibitory function . J Immunol. 162:1999;5917.
54. Kung S.K., Su R.C., Shannon J., Miller R.G. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J Immunol. 162:1999;5876.
55. Olcese L., Cambiaggi A., Semenzato G., Bottino C., Moretta A., Vivier E. Killer-cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by human killer cells. J Immunol. 158:1997;5083.
56. Tomasello E., Olcese L., Vely F., Geourgeon C., Blery M., Moqrich A., Gautheret D., Djabali M., Mattei M.G., Vivier E. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem. 273:1998;34115.
57. Mason L.H., Willette-Brown J., Anderson S.K., Gosselin P., Shores E.W., Love P.E., Ortaldo J.R., McVicar D.W. Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol. 160:1998;4148.
58. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703.
59. Smith K.M., Wu J., Bakker A.B.H., Phillips J.H., Lanier L.L. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol. 161:1998;7.
60. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP-12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693.
61. Campbell K.S., Colonna M. DAP12 a key accessory protein for relaying signals by natural killer cell receptors . Int J Biochem Cell Biol. 31:1999;631.
62. Campbell K.S., Cella M., Carretero M., Lopez-Botet M., Colonna M. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur J Immunol. 28:1998;599.
63. McVicar D.W., Taylor L.S., Gosselin P., Willette-Brown J., Mikhael A.I., Geahlen R.L., Nakamura M.C., Linnemeyer P., Seaman W.E., Anderson S.K., Ortaldo J.R., Mason L.H. DAP12-mediated signal transduction in natural killer cells. A dominant role for the syk protein-tyrosine kinase. J Biol Chem. 273:1998;32934.
64. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:1999;730.
65. Vivier E., Rochet N., Kochan J.-P., Presky D.H., Schlossman S.F., Anderson P. Structural similarities between Fc receptors and T cell receptors expression of the γ subunit of FcεRI in human T cells, NK cells and thymocytes . J Immunol. 147:1991;4263.
66. Malissen B., Schmitt-Verhulst A.-M. Transmember signalling through the T-cell-receptor-CD3-complex. Curr Opin Immunol. 5:1993;324.
67. Weiss A., Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263.
68. O'Shea J.J., McVicar D.W., Kuhns D.B., Ortaldo J.R. A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of Herbimycin A. J Immunol. 148:1992;2497.
69. Marti F., Xu C.W., Selvakumar A., Brent R., Dupont B., King P.D. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA. 95:1998;11810.
70. Bléry M., Delon J., Trautmann A., Cambiaggi A., Olcese L., Biassoni R., Moretta L., Chavrier P., Moretta A., Daëron M., Vivier E. Reconstituted killer-cell inhibitory receptors for MHC Class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J Biol Chem. 272:1997;8989.
71. Long E.O. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 17:1999;875.
72. Colonna M., Lopez-Botet M., Navarro F. A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. Curr Top Microbiol Immunol. 244:1999;115.
73. Borges L., Fanger N., Cosman D. Interactions of LIRs, a family of immunoreceptors expressed in myeloid and lymphoid cells, with viral and cellular MHC class I antigens. Curr Top Microbiol Immunol. 244:1999;123.
74. Meyaard L. LAIR-1, a widely distributed human ITIM-bearing receptor on hematopoietic cells. Curr Top Microbiol Immunol. 244:1999;151.
75. Braud V.M., McMichael A.J. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E. Curr Top Microbiol Immunol. 244:1999;85.
76. Salcedo M. Inhibitory role of murine Ly49 lectin-like receptors on natural killer cells. Curr Top Microbiol Immunol. 244:1999;96.
77. Hanke T., Takizawa H., McMahon C.W., Busch D.H., Pamer E.G., Miller J.D., Altman J.D., Liu Y., Cado D., Lemonnier F.A., Bjorkman P.J., Raulet D.H. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity. 11:1999;67.
78. Kubagawa H., Cooper M.D., Chen C.-C., Ho L.H., Alley T.L., Hurez V., Tun T., Uehara T., Shimada T., Vivier E., Burrows P.D. Paired immunoglobulin-like receptors of activating and inhibitory types. Curr Top Microbiol Immunol. 244:1999;137.
79. Daëron M., Vivier E. Biology of immunoreceptor tyrosine-based inhibition motif bearing molecules. Curr Top Microbiol Immunol. 244:1999;1.
80. Daëron M., Fridman W.H., Malbec O. Negative regulation of hematopoietic cell activation and proliferation by FcγRIIB. Curr Top Microbiol Immunol. 244:1999;13.
81. Cornall R.J., Cyster J.G., Goodnow C.C. Regulation of B cell antigen receptor signaling by the Lyn/CD22/Shp1 pathway. Curr Top Microbiol Immunol. 244:1999;57.
82. Wagtmann N. gp49 an Ig-like receptor with inhibitory properties on mast cells and natural killer cells . Curr Top Microbiol Immunol. 244:1999;106.
83. Xu R., Pecht I. The mast cell function-associated antigen, a new member of the ITIM family. Curr Top Microbiol Immunol. 244:1999;159.
84. Kharitonenkov A., Chen Z., Sures I., Wang H., Schilling J., Ullrich A. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature. 386:1997;181.
85. Jiang P., Lagenaur C.F., Narayanan V. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem. 274:1999;559.
86. Perez-Villar J.J., Whitney G.S., Bowen M.A., Hewgill D.H., Aruffo A.A., Kanner S.B. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway involvement of SH2-containing phosphotyrosine phosphatase SHP-1 . Mol Cell Biol. 19:1999;2903.
87. Adachi T., Flaswinkel H., Yakura H., Reth M., Tsubata T. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol. 196:1998;4662.
88. Taylor V.C., Buckley C.D., Douglas M., Cody A.J., Simmons D.L., Freeman S.D. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J Biol Chem. 274:1999;11505.
89. Newton-Nash D.K., Newman P.J. A new role for platelet-endothelial cell adhesion molecule-1 (CD31) inhibition of TCR-mediated signal transduction . J Immunol. 163:1999;682.
90. Barclay A.N., Brown M.H., Law S.K.A., McKnight A.J., Tomlinson M.G., Van Der Merwe P.A. The Leucocyte Antigen Facts Book. 1997;Academic Press, San Diego.
91. Arase N., Arase H., Park S.Y., Ohno H., Ra C., Saito T. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1 1(+) T cells . J Exp Med. 186:1997;1957.